2014

Christel Häggström:“Competing risk analysis of metabolic factors and prostate cancer.”European association of urology, Stockholm, Sweden. April 2014. Accepted for presentation.

2013

Christel Häggström“Competing risk analysis of metabolic factors and prostate cancer”, poster presentation.European congress of epidemiology, Århus, Denmark. August 2013.

Hanno Ulmer:“Statistical methods in the Metabolic syndrome and Cancer project (Me-Can)”. Biometrisches Kolloquium und ROeS Seminar. Dornbirn, Austria. September 2013.

Sara Wirén:“Height and risk of urological cancer.”National Urological meeting, Linköping, Sweden. October 2013.

2012

Hanno Ulmer:“Metabolic syndrome and cervical cancer in the Metabolic Syndrome and Cancer Project (Me-Can).”Womens Health 2012, The 20th Annual Congress, Washington DC, US. March 2012.

Christel Häggström“Preliminary results from multi-state models of metabolic factors and prostate cancer risk.” Survival Analysis for Junior Researchers, Leicester, UK. April 2012.

Christel Häggström:“Competing risk analysis of metabolic factors and prostate cancer“. Annual national andrology meeting, Umeå, Sweden. June 2012.

Gabriele Nagel:”Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can)”. European Congress of Epidemiology, Porto. Portugal. September 2012.

Wegene Borena:“A prospective study on metabolic risk factors and gallbladder cancer incidence in 578,700 adults in the Me-Can collaborative study.” The German Society for Epidemiology 2012,Regensburg, Germany. September 2012.

Hanno Ulmer: “Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project. “ The German Society for Epidemiology 2012,Regensburg, Germany. September 2012.

Gabriele Nagel:”Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project(Me-Can)”and “The Me-Can project”. The German Society for Epidemiology 2012,Regensburg, Germany. September 2012.

Gabriele Nagel: “Diet and Cancer.” Ulm University. Nov 2012

Pär Stattin: “Metabolic risk factors and prostate cancer: Population-based studies in Me-Can. Seminars at the Dept of Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, US. Oct and Nov 2012.

Tone Bjørge, presentations locally in Norway:
“Metabolic syndrome and female cancers”. Oct 2012.
“Metabolic syndrome and cancer”. Haukeland University Hospital. Dec 2012

2011

Tanja Stocks:“Metabolic syndrome and cancer risk.” Steno diabetes centre, Gentofte, Denmark. February 2011.

Tanja Stocks: “Metabolic factors: Common soil between cardiovasular disease and cancer”. Gene x environment interaction workshop, Umeå University, Sweden. February 2011.

Michael Edlinger:“Metabolic syndrome and risk of brain tumour in a large population-based cohort study. “IEA World Congress of Epidemiology, Edinburgh, UK. August 2011.

Susanne Strohmaier: “Total serum cholesterol and cancer incidence in the metabolic syndrome and cancer project (ME-CAN).” IEA World Congress of Epidemiology, Edinburgh, UK. August 2011.

Gabriele Nagel: “Metabolic syndrome and cervical cancer in the metabolic syndrome and cancer project.” IEA World Congress of Epidemiology, Edinburgh, UK. August 2011.

Christel Häggström:“Metabolic syndrome and risk of renal cell carcinoma.” National Urological meeting, Uppsala, Sweden. October 2011.

Christel Häggström: “Competing risk analysis of metabolic factors and prostate cancer.” National Urological meeting, Uppsala, Sweden. October 2011.

Christel Häggström:“An example of competing risk analysis using prostate cancer data“. Nordic STATA user group meeting, Stockholm, Sweden. November 2011.

Michael Edlinger:“The effect of regression dilution bias on the association between metabolic sydrom and brain tumors in a large population-based cohort study“.Biometrisches Kolloquium und ROeS Seminar, Zürich, Schweiz, November 2011.

2010

Pär Stattin:“Metabolic syndrome and prostate cancer risk.” European Association of Urology, Barcelona,Spain. April 2010.

Wegene Borena:“Serum triglycerides and cancer risk in the metabolic syndrom and cancer (Me-Can) collaborative study.”WCRF conference on Nutrition, Physical activity and Cancer Prevention, London, UK. September 2010.

Tanja Stocks:“Metabolic factors and colorectal cancer risk in the Metabolic syndrome and Cancer project (Me-Can)”. WCRF conference on Nutrition, Physical activity and Cancer Prevention, London, UK. September 2010.

Tanja Stocks: “The Metabolic syndrome and Cancer project (Me-Can).” Institute of Preventive Medicine, Copenhagen, Denmark. November, 2010.

2009

Hanno Ulmer:“Metabolic syndrome and cervical cancer in the Metabolic Syndrome and Cancer Project.”Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie Mainz, Germany. September 2009.

Christel Häggström: “Metabolic syndrome and risk of 1) renal cell carcinoma and 2) prostate cancer.”National Urological meeting, Göteborg, Sweden. October 2009.